Search
for
Sort by
Research 781–810 of 1000+
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients
- Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study
- Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3
- 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- Trajectories For Scalp Hair Regrowth In Patients With Severe Alopecia Areata Treated With Baricitinib
- Scalp hair repigmentation after radiotherapy
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- What amount of hair do women want?
- An update on the pathophysiology of female pattern hair loss
- Genetic Markers of Male and Female Pattern Hair Loss
- Prevalence of Male and Female Pattern Hair Loss in Maryborough
- Treatment of female pattern hair loss with oral antiandrogens
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Follicular miniaturization in female pattern hair loss: clinicopathological correlations
- Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know
- Gene-wide association study between the aromatase gene (<i>CYP19A1</i>) and female pattern hair loss
- Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
- Hair colouring, permanent styling and hair structure
- Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
- Beyond goosebumps: Does the arrector pili muscle have a role in hair loss?
- Treatment of female pattern hair loss with the androgen receptor antagonist flutamide
- Women who present with female pattern hair loss tend to underestimate the severity of their hair loss
- Association analysis of oestrogen receptor beta gene ( <i>ESR2</i> ) polymorphisms with female pattern hair loss
- Miniaturized hairs maintain contact with the arrector pili muscle in alopecia areata but not in androgenetic alopecia: A model for reversible miniaturization and potential for hair regrowth
- Treatment of female pattern hair loss with a combination of spironolactone and minoxidil